Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use. The main objectives are to: * Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury * To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program. Participants will: * Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit * Complete Treatment Effectiveness Assessments at 6 and 12-weeks * Engage in a qualitative interview at the end of the CM program
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
The Queen's Medical Center
Honolulu, Hawaii, United States
Start Date
October 10, 2024
Primary Completion Date
September 30, 2025
Completion Date
September 30, 2025
Last Updated
January 22, 2025
20
ESTIMATED participants
Contingency Managment
BEHAVIORAL
Lead Sponsor
Queen's Medical Center
Collaborators
NCT06899594
NCT07086014
NCT05322954
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions